We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » India’s Serum Institute Begins Producing Codagenix’s COVID-19 Vaccine Candidate
India’s Serum Institute Begins Producing Codagenix’s COVID-19 Vaccine Candidate
New York biotech Codagenix announced Tuesday that the Serum Institute of India has begun manufacturing its intranasal COVID-19 vaccine candidate, CDX-005.